GO
Loading...

Poor Q1 for Pfizer, not giving up: Pro

Monday, 5 May 2014 | 12:13 PM ET

Discussing Pfizer's bid for AstraZenaca, and whether his firm will continue to hold its shares, with Sam Isaly of OrbiMed Advisors.